t
| Date | 24 Feb 2023 |
| Time | 07:00:05 |
| Category | Miscellaneous |
| ID | 9191Q |
24 February 2023
Belluscura plc
("Belluscura" or the "Company")
Belluscura's X-PLOR® portable oxygen concentrator now marketed through GoodRx®
Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that the X-PLOR portable oxygen concentrator ("POC") is now marketed in the US through GoodRx, Inc. www.goodrx.com The X-PLOR will be the first medical device in its field marketed by GoodRx, Inc.
GoodRx, Inc (Nasdaq: GDRX) is a leading digital healthcare platform that makes healthcare affordable and convenient for all Americans. The company offers consumers free access to transparent and lower prices for branded and generic medications, affordable and convenient medical provider consultations via telehealth, and comprehensive healthcare research and information. Since 2011, GoodRx has helped consumers save over $45 billion and has been one of the most downloaded medical apps over the past decade.
Commenting on the new marketing portal, Robert Rauker, Chief Executive Officer, Belluscura plc, said:
"In our continued goal of broadening product distribution and making supplemental oxygen more accessible to people throughout the US, we are excited to have the X-PLOR marketed through GoodRx, a recognized leader in making healthcare more accessible and affordable in the US."
ENDS
For further information, please contact:
|
Belluscura plc |
www.belluscura.com |
|
Robert Rauker, Chief Executive Officer |
via MHP |
|
Anthony Dyer, Chief Financial Officer |
|
|
|
|
|
SPARK Advisory Partners Limited (NOMAD) |
Tel: +44 (0)20 3368 3550 |
|
Neil Baldwin |
|
|
|
|
|
Dowgate Capital Limited (Broker) |
Tel: +44 (0)20 3903 7715 |
|
James Serjeant / Nicholas Chambers |
|
|
|
|
|
MHP Communications (Financial PR and Investor Relations) |
Tel: +44 (0)20 3128 8100 |
|
Katie Hunt / Pete Lambie / Matthew Taylor |
Email: [email protected] |
|
|
|
About Belluscura plc ( www.belluscura.com )
Belluscura is a UK medical device company focused on developing high performing, lightweight and portable oxygen enrichment technology used in a broad range of industries and therapies. Our innovative oxygen technologies are designed with a global purpose: to create improved health, mobility and economic outcomes for patients, healthcare providers and insurance organisations.
About RNS Reach announcements
Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.